Arcutis Biotherapeutics Inc (ARQT)
8.36
-0.30
(-3.46%)
USD |
NASDAQ |
May 31, 16:00
8.35
-0.01
(-0.12%)
After-Hours: 20:00
Arcutis Biotherapeutics Cash from Operations (Quarterly): -31.60M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -31.60M |
| December 31, 2023 | -56.24M |
| September 30, 2023 | -43.98M |
| June 30, 2023 | -66.48M |
| March 31, 2023 | -80.34M |
| December 31, 2022 | -71.06M |
| September 30, 2022 | -67.70M |
| June 30, 2022 | -61.98M |
| March 31, 2022 | -56.98M |
| December 31, 2021 | -51.71M |
| September 30, 2021 | -40.88M |
| Date | Value |
|---|---|
| June 30, 2021 | -35.83M |
| March 31, 2021 | -46.20M |
| December 31, 2020 | -32.57M |
| September 30, 2020 | -33.69M |
| June 30, 2020 | -25.76M |
| March 31, 2020 | -21.01M |
| December 31, 2019 | -16.80M |
| September 30, 2019 | -10.72M |
| June 30, 2019 | -8.243M |
| March 31, 2019 | -7.074M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-80.34M
Minimum
Mar 2023
-8.243M
Maximum
Jun 2019
-42.99M
Average
-42.43M
Median
Cash from Operations (Quarterly) Benchmarks
| Heron Therapeutics Inc | -9.516M |
| Marinus Pharmaceuticals Inc | -37.46M |
| Insmed Inc | -184.04M |
| Agios Pharmaceuticals Inc | -99.87M |
| AdaptHealth Corp | 49.04M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -28.70M |
| Cash from Financing (Quarterly) | 161.76M |
| Free Cash Flow | -198.32M |
| Free Cash Flow Per Share (Quarterly) | -0.2846 |
| Free Cash Flow to Equity (Quarterly) | -32.61M |
| Free Cash Flow to Firm (Quarterly) | -24.05M |
| Free Cash Flow Yield | -29.01% |